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Haploinsufficiency of a Spliceosomal GTPase
Encoded by EFTUD2 Causes Mandibulofacial
Dysostosis with Microcephaly
Matthew A. Lines,1 Lijia Huang,1 Jeremy Schwartzentruber,2 Stuart L. Douglas,1 Danielle C. Lynch,1
Chandree Beaulieu,1 Maria Leine Guion-Almeida,3 Roseli Maria Zechi-Ceide,3 Blanca Gener,4
Gabriele Gillessen-Kaesbach,5 Caroline Nava,6 Genevie`ve Baujat,6 Denise Horn,7 Usha Kini,8
Almuth Caliebe,9 Yasemin Alanay,10,11 Gulen Eda Utine,10 Dorit Lev,12 Ju¨rgen Kohlhase,13
Arthur W. Grix,14 Dietmar R. Lohmann,15 Ute Hehr,16 Detlef Bo¨hm,13 FORGE Canada Consortium,17
Jacek Majewski,18 Dennis E. Bulman,19 Dagmar Wieczorek,15,20 and Kym M. Boycott1,20,*
Mandibulofacial dysostosis with microcephaly (MFDM) is a rare sporadic syndrome comprising craniofacial malformations, micro-
cephaly, developmental delay, and a recognizable dysmorphic appearance. Major sequelae, including choanal atresia, sensorineural
hearing loss, and cleft palate, each occur in a significant proportion of affected individuals. We present detailed clinical findings in
12 unrelated individuals with MFDM; these 12 individuals compose the largest reported cohort to date. To define the etiology of
MFDM, we employed whole-exome sequencing of four unrelated affected individuals and identified heterozygous mutations or dele-
tions of EFTUD2 in all four. Validation studies of eight additional individuals with MFDM demonstrated causative EFTUD2 mutations
in all affected individuals tested. A range of EFTUD2-mutation types, including null alleles and frameshifts, is seen in MFDM, consistent
with haploinsufficiency; segregation is de novo in all cases assessed to date. U5-116kD, the protein encoded by EFTUD2, is a highly
conserved spliceosomal GTPase with a central regulatory role in catalytic splicing and post-splicing-complex disassembly. MFDM is
the first multiple-malformation syndrome attributed to a defect of the major spliceosome. Our findings significantly extend the range
of reported spliceosomal phenotypes in humans and pave the way for further investigation in related conditions such as Treacher Collins
syndrome.Mandibulofacial dysostosis (MFD) is a disturbance in the
development of the first and second branchial arches and
causes malar and mandibular hypoplasia, a cleft palate,
and/or conductive hearing loss. Although several distinct
MFD syndromes are recognized, the most well understood
is Treacher Collins syndrome (MIM 154500), a common,
isolated form caused by mutations of three genes involved
in pre-rRNA transcription.1,2 Of the several other recog-
nized mandibulofacial and acrofacial dysostoses, only the
gene associated with Miller syndrome (MIM 263750) has
been identified; this gene encodes an enzyme involved in
pyrimidine biosynthesis.3 Etiologies of the remaining
MFD syndromes remain unknown.
In 1996, Guion-Almeida et al.4 described four individ-
uals with a distinct sporadic syndrome (MIM 610536)
combining MFD with microcephaly, growth and develop-
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The Americaear malformations with preauricular tags. Two subsequent
reports5,6 described a total of five phenotypically similar
individuals, and the inheritance pattern was again
sporadic with the exception of a single affected mother
and son.6 To further delineate the phenotype of this condi-
tion, which we have provisionally termed ‘‘MFD with
microcephaly’’ (MFDM), we assembled a cohort of 12
unrelated affected individuals, including five previously
reported persons.4,5 The phenotype of all 12 individuals
with MFDM (Table 1; Figure 1) is characterized by micro-
cephaly, midface hypoplasia, micrognathia, and a charac-
teristic external ear appearance. Microcephaly in this
condition is both progressive and severe and might be of
either pre- or postnatal onset. A significant deceleration
of head growth is seen during infancy, and head circumfer-
ence eventually falls to between 3 and 6 standard devia-
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Table 1. Phenotype of Individuals with MFDM
Individual
1 2 3 4 5 6 7 8 9 10 11 12
Reference this report Wieczorek5,
‘‘patient 2’’
Wieczorek5,
‘‘patient 3’’
Guion-Almeida4,
‘‘patient 2’’
this report this report Wieczorek5,
‘‘patient 1’’
this report Guion-Almeida4,
‘‘patient 1’’
this report this report this report
Inheritance sporadic sporadic sporadic sporadic sporadic sporadic sporadic sporadic sporadic sporadic sporadic sporadic
Sex M M F M F M F F M M F M
Consanguinity - - - - - - - - þ (f ¼ 1/16) - - -
Paternal age (years) 35 N/R N/R 28 N/R 26 N/R 31 25 N/R N/R N/R
Pregnancy
complications
N/R N/R increased NT and
microcephaly
N/R IUGR N/R PROM - - - poly-
hydramnios
increased NT
Gestation (weeks) 37 42 39 full term (number
of weeks not
available)
40 39 33 41þ3 full term (number
of weeks not
available)
40 41þ4 42
Birth weight (g) 2,150
(2 SD)
3,180
(1.5 SD)
2,850
(1.25 SD)
3,100 2,610
(2 SD)
2,400
(2.5 SD)
1,500
(1.5 SD)
3,870
(þ0.5 SD)
3,500 3,000
(1 SD)
3,330
(1 SD)
3,161
(1.5 SD)
Birth head
circumference (cm)
30.5
(1.75 SD)
33
(2 SD)
30
(3 SD)
N/R 31
(2.75 SD)
N/R 27 (2 SD) 32.5 (2 SD) N/R 33 (1 SD) 31
(3.5 SD)
N/R
Age at last
assessment
3 years 7 years,
8 months
6 years,
5 months
9 years,
5 months
2 years,
7 months
1 year,
2 months
7 years,
2 months
2 years 13 years,
4 months
2 years,
5 months
1 year 7 years,
2 months
Head
circumference
(cm)
(3.5 SD) 47 (3.5 SD) 43.8 (5 SD) 48 (3.5 SD) 43.5 (4 SD) 43 (3 SD) 42.5 (6 SD) 42 (5 SD) 50 (3 SD) 44.5 (4 SD) 39.8 (5 SD) 46.4
(4 years,
9 months)
(3 SD)
Weight (kg) normal 24 (þ0 SD) 22.5 (þ0 SD) 24 (2 SD) 13.4 (þ0 SD) 8 (3.5 SD) 24 (þ0 SD) 10.3 (2 SD) 38 (1.5 SD) 12.7 (0.75 SD) 6.72 (4 SD) 22.6 (7 years,
2 months)
(þ0 SD)
Height (cm) normal 122 (1 SD) 117.4 (þ0 SD) 131 (1 SD) 87 (1.75) 71 (3 SD) 118 (1 SD) 84 (0.25 SD) 151 (1.25 SD) 89 (0.75 SD) 69 (2 SD) 116.6 (7 years,
2 months)
(1.5 SD)
Malar hypoplasia þ þ þ þ þ þ þ þ þ þ - þ
Micrognathia þ þ þ þ þ þ þ þ þ þ þ þ
Obliquity
of palpebrae
upslanting upslanting level one
downslanting
upslanting downslanting upslanting downslanting þ level level level
Lower-eyelid cleft - þ - - - - - - - þ bilateral -
Microtia þ þ þ þ þ þ þ þ þ þ þ N/R
Preauricular tags þ unilateral bilateral þ unilateral unilateral unilateral - þ unilateral - unilateral
Auditory canal
atresia or stenosis
N/R bilateral unilateral - unilateral N/R bilateral þ - bilateral unilateral -
Hearing loss conductive conductive conductive N/A conductive sensorineural conductive conductive - conductive conductive conductive
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Table 1. Continued
Individual
1 2 3 4 5 6 7 8 9 10 11 12
Midline cleft
palate (including
submucous)
- þ - þ þ bifid uvula - - þ þ þ -
Choanal atresia þ bilateral unilateral - N/R N/R bilateral bilateral - - - bilateral
Need for neonatal
resuscitation
þ - - - - þ þ - - - - -
Tracheostomy þ - - - - - - - - - - -
Global
developmental
delay
þ mild to
moderate
mild moderate
to severe
moderate
to severe
þ moderate moderate severe mild to
moderate
mild to
moderate
moderate
Age at walking
(months)
28 16 24 17 24–36 N/R 24 24 60 19 NM 19
Age at first
words (months)
NM 24 20 24 NM N/R 30 NM NM NM NM N/R
Brain MRI normal delayed
myelination
at 15 months
of age
normal N/R N/R N/R N/R N/R N/R abnormal
white matter
on FLAIR
N/R N/R
Seizures N/R þ - þ - N/R þ - þ þ - -
Gastrostomy þ - þ - - - - - - N/R - -
Metopic ridge þ þ - þ þ þ - - þ N/R - þ
Congenital
heart defect
- ASD - - VSD ASD mild PPS - ASD ASD ASD -
Proximally
placed thumb
þ - þ N/R N/R þ - - N/R N/R - þ
Duplicated thumb - - - - - - - - þ N/R - -
Other anomalies cryptorchidism
and small
scrotum
hypoplastic
toenails and
delayed bone
age
myopia, middle
ear and vestibular
hypoplasia
- - cryptorchidism
and small
scrotum
- - - N/R - -
Karyotype 46,XY N/R 46,XX 46,XY 46,XX N/R 46,XX 46,XX 46,XY 46,XY 46,XX 46,XY
Microarray
(hg19)
see Table 2 normal N/R N/R see Table 2 N/R N/R normal N/R normal N/R normal
EFTUD2
mutation
(see Table 2)
deletion
of last nine
exons
p.Arg262Trp p.Gln924* p.Ser586fs*19 complex
rearrangement
causing deletion
p.Arg262fs*1 p.Ser391fs*57 p.Gln719* p.Tyr831* intron 16 50
splice site
p.Leu637Arg p.Cys476Arg
Abbreviations are as follows: N/R, not reported; NT, nuchal translucency; IUGR, intrauterine growth restriction; PROM, premature rupture of membranes; N/A, not assessed; NM,milestone not yet met; FLAIR, fluid attenuated
inversion recovery; ASD, atrial septal defect; VSD, ventricular septal defect; and PPS, peripheral pulmonic stenosis.
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Figure 1. Characteristic Craniofacial Dysmorphism in MFDM
The detailed clinical description of these individuals is reported in Table 1. Typical findings include a sloping forehead,malar hypoplasia,
micrognathia, a widemouth, and a characteristic external ear appearance (preauricular tags, microtia, a small superior helix, and a prom-
inent lobe with a square posterior margin). Microtia is variable in severity; some patients have a cupped ear configuration.
(A) Individual 11: birth
(B) Individual 11: 19 months
(C) Individual 8: 8 months
(D) Individual 8: 24 months
(E) Individual 12: 7 years
(F) Individual 3: 6 years, 5 months
(G) Individual 2: 3.5 years (left) and 10.5 years (right)
(H) Individual 9: 13 years, 5 months
(I) Individual 4: 16 years, 8 monthsidentified to date have shown significant global develop-
mental delay, and expressive language is particularly
affected (only half of our cohort has attained any speech
whatsoever; first words are generally spoken between
20 and 30 months). Of the four individuals who have
had brain imaging, magnetic resonance imaging (MRI)
was normal in two, whereas nondiagnostic abnormalities
(delayedmyelination or nonspecificwhite-matter changes)
were seen in the other two individuals. Additional
commonly seen major malformations included choanal
and aural atresia, cleft palate, and congenital heart defects
(typically atrial septal defects), and each was present in
more than half of the affected individuals. Hearing loss,
generally conductive, was reported in 10 of the 12 individ-
uals. Minor anomalies that were inconsistently observed
included cryptorchidism and proximally placed thumbs.
Despite the scarcity of prior clinical reports, themultiplicity
of findings in our cohort is such that we consider MFDM to
be a distinct, clinically recognizable syndrome.
To determine the genetic basis of MFDM, we performed
exome capture and high-throughput sequencing of four
unrelated affected individuals. We obtained approval of
the study design from the institutional research ethics
board (Children’s Hospital of Eastern Ontario), and
informed consent was obtained from responsible persons372 The American Journal of Human Genetics 90, 369–377, February(parents) on behalf of all study participants. We performed
target enrichment by using the Agilent SureSelect
50 Mb All Exon Kit, and sequencing (Illumina Hiseq)
generated >12 Gbp of 100 bp paired-end reads per sample.
Variant calling and annotation were performed as follows
(see Web Resources): Reads were preprocessed (trimmed),
and sequences with a matching (opposite) read were
aligned to hg19 with Burrows-Wheeler Aligner.7 Duplicate
reads were marked with Picard and were excluded. Single-
nucleotide variants and short in/dels were called with
SAMtools pileup and varFilter8 and were quality-filtered
so that at least 20% of the reads supported the variant
call. We annotated the variants by using Annovar9 and
custom scripts to select coding and splice-site variants
and to exclude common (R1% minor allele frequency)
polymorphisms represented in dbSNP131, the 1000
Genomes pilot release, or in 120 local exomes performed
at our center. We performed genome-wide copy-number
analysis in parallel for each of the four affected individuals
by microarray (Illumina Human Omni2.5).
We next tabulated the rare variants seen in our cohort
and compared them between the probands to prioritize
genes of interest. Because the mode of inheritance of
MFDM was not known a priori, our data were considered
under both an autosomal-dominant (one variant per10, 2012
Table 2. Rare-Variant Analysis in Individuals with MFDMa
Any X of Four Individuals 1 2 3 4
Genes containing missense, nonsense,
in/del, or splice-site variants
2,523 196 18 2
Allele frequency of %1% in dbSNP131,
1000 Genomes, and 120 local exomes
1,474 161 8b 1 (MUC4)c
a With a dominant model of disease.
b Including EFTUD2.
c Private MUC4 variants are a frequent finding at our center; therefore, this
gene was deliberately excluded from further analysis.gene per proband) and an autosomal-recessive (two vari-
ants per gene per proband) model. Apart from MUC4
(a frequent ‘‘false positive’’ in whole-exome studies at our
center), no genes satisfied a recessive model in all four
probands after filtering; therefore, an identifiable recessive
locus for MFDM was deemed unlikely. Next, applying
a dominant model, we noted that eight genes contained
variants in three out of four MFDM exomes (Table 2). Of
these eight genes, one (EFTUD2) was noted to have a region
of reduced read depth in the remaining (fourth) proband
(Figure 2); microarray confirmed a corresponding deletion
of the last nine exons of EFTUD2 in this individual. To
verify EFTUD2 as the gene associated with MFDM, we
analyzed EFTUD2 in a further eight individuals with
MFDM. We identified heterozygous mutations in seven
cases, and in the eighth individual, we found a complex
de novo chromosomal rearrangement causing heterozy-
gous deletion of EFTUD2 (Table 3, Figure 2, and Figures
S1 and S2). A wide variety of mutation types, including
large deletions, frameshifts, and splice-site, nonsense,
and missense mutations, were observed, consistent with
haploinsufficiency. Mutations were not represented inThe Americamore than 10,000 exomes contained within the National
Heart, Lung, and Blood Institute (NHLBI) Exome Variant
Server (see Web Resources), and they were determined to
be de novo in all seven cases in which parental samples
were obtainable. Taken together, our findings are consis-
tent with de novo haploinsufficiency of EFTUD2 as the
cause of MFDM in all cases assessed to date.
Because 2 of the 12members in our cohort were found to
have a microdeletion identifiable on the array, we next
considered the spectrum of normal variation within
EFTUD2. The Database of Genomic Variants does not
contain any copy-number variants overlapping EFTUD2.
Additionally, neither dbSNP nor the Exome Variant Server
contains any truncating single-nucleotide polymorphisms
within this gene. DECIPHER does contain one individual
(249945) bearing a small deletion overlapping EFTUD2
and two adjacent genes, but the phenotype of this indi-
vidual is not specified. EFTUD2 deletions or truncating
mutations are therefore not represented in existing catalogs
of normal genomic variation in the general population.
EFTUD2 encodes U5-116kD, a highly conserved spliceo-
somal GTPase with striking sequence similarity to the ribo-
somal translation elongation factor EF-2.10 The domain
architecture of U5-116kD is comparable to that of other
EF-related proteins, consisting of a GTP-binding domain
and additional conserved domains II–V; both U5-116kD
and its (better known) S. cerevisiae homolog, Snu114p,
also have a N-terminal acidic domain of unknown func-
tion not present in other members of this family.10
Although there are currently no reported phenotypes for
EFTUD2 in metazoa, the functions of both U5-116kD
and Snu114p have been thoroughly characterized. In the
spliceosome, Snu114p occupies a central position within
the U4/U6-U5 tri-snRNP particle,11 where it forms a stableFigure 2. Locations of Disease-Causing
Mutations in EFTUD2
(A) Intron-exon structure of EFTUD2
(introns not to scale) with the locations
of ten MFDM-causing point mutations
(relative to NM_004247.3). Missense
mutations are shown in blue, truncating
(nonsense and frameshift) mutations are
shown in red, and the intron 16 splice-
donor mutation is shown in green.
(B) Domain architecture of U5-116kDa
(after Fabrizio et al., 1997)7 indicates the
locations of point mutations (the color
scheme is the same as that in A).
(C) Exome-sequencing read depth in pro-
band 1 shows a zone of reduced coverage
(dashed box) extending from exons 20–
29 of EFTUD2 into the adjoining gene
(HIGD1B). A corresponding microdeletion
was confirmed by microarray (coordinates
are listed in Table 3).
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Table 3. EFTUD2 Mutations and Deletions in Individuals with MFDM
Individual Nucleotide Peptide Inheritance Predicted Effect
1a chr17: 42923422–42935059 3 1 N/A deletion of last nine exons
2a c.784C>T p.Arg262Trp de novo missense
3a c.2770C>T p.Gln924* de novo nonsense
4a c.1758_1759del p.Ser586fs*19 N/A frameshift
5 chr17: 42792021–43147305 3 1
chr17: 41993587–42253276 3 3
chr4: 59109311–59427079 3 1
de novo deletion affecting 11 genes
(including EFTUD2); duplication
of a further ten genes
6 c.784_787deldup788_799
TGATCCTGGAGC
p.Arg262fs*1 N/A frameshift
7 c.1172_1179del p.Ser391fs*57 de novo frameshift
8 c.2155C>T p.Gln719* de novo nonsense
9 c.2493C>A p.Tyr831* de novo nonsense
10 c.1607þ3A>G p.Tyr537fs*25 (predicted) N/A 50 splice site, intron 1b
11 c.1910T>G p.Leu637Arg de novo missense
12 c.1426T>C p.Cys476Arg N/A missense
cDNA positions given are relative to NM_004247.3. Chromosome reference positions are relative to hg19. Primer sequences and sequencing chromatograms are
provided in Table S1 and Figure S1. Chromosome rearrangements in individuals 1 and 5 are depicted in Figure S2. The following abbreviation is used: N/A, not
Assessed.
a Discovery (exome) cohort participant.
b Predicted in silico to abolish splicing (see Web Resources).complex with two catalytically essential RNA helicases,
Brr2p and Prp8p.12 Snu114p is essential for Brr2p-medi-
ated dissociation of U4 and U6 RNAs; this dissociation is
a key event during catalytic splicing.13 After splicing,
Snu114p is also required for the disassembly and subunit
recycling of the postsplicing intron complex; a model
has been proposed in which Snu114p acts as a central
‘‘GTP switch’’ regulating both splicing and disassembly.14
In keeping with this important role in gene expression,
Snu114p is an essential yeast protein, alterations of which
cause temperature-sensitive growth arrest accompanied by
the accumulation of unspliced transcripts.15,16 Interest-
ingly, all three of the EFTUD2 missense mutations (result-
ing in amino acid substitutions p.Arg262Trp, p.Cys478Arg,
and p.Leu637Arg) seen in our cohort occur at (or adjacent
to) corresponding Snu114p temperature-sensitive alter-
ations (p.Asp271Asn, p.Arg487Glu, and p.Asp653Val,
respectively) in yeast.15,16 A U5-116kD structural model
(Figure 3) based on the crystal structure of S. cerevisiae
EF-217 places these three alterations in disparate domains
of theprotein; Arg262 is situated in theGTP-bindingpocket
of U5-116kD, and Cys478 and Leu637 form internal
contacts indomains II and III, respectively. Because individ-
uals with alterations at these three positions demonstrate
the full clinical presentation ofMFDM, these three substitu-
tions are presumed to cause a substantial derangement of
U5-116kD function and/or stability.
U5-116kD alterations are uniquely pleiotropic in
contrast to the range of previously reported spliceosomal
phenotypes in humans. Interestingly, all four of the other374 The American Journal of Human Genetics 90, 369–377, Februaryspliceosomal subunits known to produce a clinical pheno-
type in humans (PRPF31 [MIM 606419], PRPF8 [MIM
607300], SNRNP200 [MIM 601664], and PRPF6 [MIM
613979]) cause retinitis pigmentosa, an isolated retinal
condition.18–21 The reason for this difference in pheno-
types remains unexplained because PRPF8 and, in partic-
ular, SNRNP200 encode the human homologs of Prp8p
and Brr2p—two RNA helicases that complex with (and
are regulated by) U5-116kD.11–14 Considering that splicing
is an obligatory process for gene expression in all cells,
the pertinent question is not why EFTUD2 mutations
cause a multiple-malformation syndrome with intellectual
disability, but rather why the same is not seen for all other
spliceosomal constituents. The developmental significance
of splicing defects has been similarly illustrated for the
minor spliceosome with the discovery of mutations in
a noncoding RNA gene, RNU4ATAC, as the cause of a syn-
dromic skeletal dysplasia, microcephalic osteodysplastic
primordial dwarfism type I (MIM 210710).22 Because the
U5 snRNP is common to both major and minor spliceo-
somes,23 U5-116kD and the retinopathy-associated prod-
ucts of PRPF8 and SNRNP200 are expected to participate
in both U2- and U12-dependent splicing reactions.
In addition to extending the range of reported spli-
ceosomal phenotypes, our results also highlight a path-
way affecting craniofacial development. Supported by
observations of the Tcof1þ/ mouse, the prevailing view
of mandibulofacial dysostosis holds MFD to be a conse-
quence of inadequate ribosome biogenesis in a vulnerable
population of neural-crest precursors.24 In keeping with10, 2012
Figure 3. Predicted Structural Effects of MFDM-Causing Missense Mutations
We modeled residues 114–957 of EFTUD2 on the crystal structure of S. cerevisiae ribosomal elongation factor 2 (eEF2)14 by using
ModWeb, and we visualized them in PyMol.
(A) Crystal structure of eEF2 (PDB: 1N0U) complexed with the translation inhibitor sordarin (yellow). Structural domains are high-
lighted.
(B) U5-116kDmodel based on eEF2. Themodeled portion of U5-116kD has high identity (37%) with eEF2; ModWeb scores this model as
‘‘reliable’’ (GA341 score is 1.00).
(C) Locations of amino acid substitutions p.Arg262Trp, p.Cys476Arg, and p.Leu637Arg.
(D) Arg262 (red) is predicted to occupy surface of GTP binding site. Also highlighted are additional surface-facing residues of G1 (green),
G4 (yellow), and G5 (orange) motifs.
(E) Arg262Trp alteration in individual 2 is predicted to alter GTP-binding surface topology.
(F) Leu637 sidechain (helix II of domain III) is predicted to face inward and to form close hydrophobic contacts with Ile590 and Ile629.
Leu637Arg (individual 11) is predicted to introduce a positive charge at this location.
(G) Cys476 is situated at the center of domain II’s b barrel structure. p.Cys476Arg (individual 12) is predicted to introduce a positive
charge at this position.
(H) Multispecies alignments of U5-116kDa illustrate sequence conservation in the vicinity of missense mutations identified in individ-
uals with MFDM.
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this, craniofacial malformations akin to those found in
Treacher Collins syndrome are indeed seen in a subset
of individuals with Diamond Blackfan anemia (MIM
105650), a ribosomopathy caused by alterations in any of
several ribosomal subunits.25 Whether altered ribosome
biogenesis is an underlying aspect of the MFDM pheno-
type, and whether this is a direct or downstream effect
remains to be determined; nonetheless, our findings point
to an alternative pathway for investigating individuals
with unexplained Treacher Collins syndrome and related
conditions.
In summary, we have shown that de novo dominant
mutations in EFTUD cause MFDM, a recognizable mandi-
bulofacial dysostosis distinguished from Treacher Collins
syndrome by microcephaly, global developmental delay,
and a characteristic pattern of additional malformations.
Because the participants in our study were selected on
the basis of a highly specific presentation, the full clinical
spectrum of MFDM is unknown. Given the apparent
high sensitivity of molecular testing in this condition, we
suggest that this syndrome should be entertained in the
differential diagnosis of any child with progressive micro-
cephaly accompanied by craniofacial malformations.Supplemental Data
Supplemental Data include two figures and one table and can be
found with this article online at http://www.cell.com/AJHG.Acknowledgments
The authors would first like to thank the study participants and
their families, without whose participation this work would not
be possible. This work was funded by the government of Canada
through Genome Canada, the Canadian Institutes of Health
Research (CIHR), and the Ontario Genomics Institute (OGI-049).
Additional funding was provided by Genome Quebec, Genome
British Columbia, and the Physicians’ Services Incorporated Foun-
dation. This work was part of the CRANIRARE Network funded
through a grant from the GermanMinistry of Research and Educa-
tion to D.R.L. and D.W. (BMBF 01GM0802). K.M.B. is supported
by a Clinical Investigatorship Award from the CIHR Institute of
Genetics. This work was selected for study by the FORGE Canada
Steering Committee, consisting of K. Boycott (University of
Ottawa), J. Friedman (University of British Columbia), J. Michaud
(University of Montre´al), F. Bernier (University of Calgary),
M. Brudno (University of Toronto), B. Fernandez (Memorial
University), B. Knoppers (McGill University), M. Samuels (Univer-
site´ deMontre´al), and S. Scherer (University of Toronto).Wewould
like to thank JanetMarcadier (clinical coordinator) forhercontribu-
tion to the infrastructure of the FORGE Canada Consortium. We
also wish to acknowledge the contribution of the high-throughput
sequencingplatformof theMcGillUniversity andGe´nomeQue´bec
Innovation Centre, Montre´al, Canada.
Received: October 27, 2011
Revised: December 12, 2011
Accepted: December 30, 2011
Published online: February 2, 2012376 The American Journal of Human Genetics 90, 369–377, FebruaryWeb Resources
The URLs for data presented herein are as follows:
Berkeley Drosophila Genome Project, Splice Site Prediction by
Neural Network, http://www.fruitfly.org/seq_tools/splice.html
Database of Genomic Variants, http://projects.tcag.ca/variation/
DECIPHER v5.1, http://decipher.sanger.ac.uk/
FASTX-Toolkit, http://hannonlab.cshl.edu/fastx_toolkit/
NHLBI Exome Variant Server, http://evs.gs.washington.edu/EVS/
ModWeb, http://modbase.compbio.ucsf.edu/ModWeb20-html/
modweb.html
Online Mendelian Inheritance in Man (OMIM), http://www.
omim.org/
Picard, http://picard.sourceforge.net/
PyMol, http://www.pymol.org/
SAMtools, http://samtools.sourceforge.net/
UCSC Genome Browser, http://genome.ucsc.edu/cgi-bin/
hgGateway/References
1. The Treacher Collins Syndrome Collaborative Group. (1996).
Positional cloning of a gene involved in the pathogenesis of
Treacher Collins syndrome. Nat. Genet. 12, 130–136.
2. Dauwerse, J.G., Dixon, J., Seland, S., Ruivenkamp, C.A., van
Haeringen, A., Hoefsloot, L.H., Peters, D.J., Boers, A.C.,
Daumer-Haas, C., Maiwald, R., et al. (2011). Mutations in
genes encoding subunits of RNA polymerases I and III cause
Treacher Collins syndrome. Nat. Genet. 43, 20–22.
3. Ng, S.B., Buckingham, K.J., Lee, C., Bigham, A.W., Tabor, H.K.,
Dent, K.M., Huff, C.D., Shannon, P.T., Jabs, E.W., Nickerson,
D.A., et al. (2010). Exome sequencing identifies the cause of
a mendelian disorder. Nat. Genet. 42, 30–35.
4. Guion-Almeida, M.L., Zechi-Ceide, R.M., Vendramini, S., and
Tabith Ju´nior, A. (2006). A new syndrome with growth and
mental retardation, mandibulofacial dysostosis, micro-
cephaly, and cleft palate. Clin. Dysmorphol. 15, 171–174.
5. Wieczorek, D., Gener, B., Gonza´lez, M.J., Seland, S., Fischer, S.,
Hehr, U., Kuechler, A., Hoefsloot, L.H., de Leeuw, N., Gillessen-
Kaesbach, G., and Lohmann, D.R. (2009). Microcephaly,
microtia, preauricular tags, choanal atresia and developmental
delay in three unrelated patients: a mandibulofacial dysostosis
distinct from Treacher Collins syndrome. Am. J. Med. Genet.
A. 149A, 837–843.
6. Guion-Almeida, M.L., Vendramini-Pittoli, S., Passos-Bueno,
M.R., and Zechi-Ceide, R.M. (2009). Mandibulofacial
syndrome with growth andmental retardation, microcephaly,
ear anomalies with skin tags, and cleft palate in a mother and
her son: autosomal dominant or X-linked syndrome? Am. J.
Med. Genet. A. 149A, 2762–2764.
7. Li, H., and Durbin, R. (2009). Fast and accurate short read
alignment with Burrows-Wheeler transform. Bioinformatics
25, 1754–1760.
8. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer,
N., Marth, G., Abecasis, G., and Durbin, R.; 1000 Genome
Project Data Processing Subgroup. (2009). The Sequence
Alignment/Map format and SAMtools. Bioinformatics 25,
2078–2079.
9. Wang, K., Li, M., and Hakonarson, H. (2010). ANNOVAR:
Functional annotation of genetic variants from high-through-
put sequencing data. Nucleic Acids Res. 38, e164.10, 2012
10. Fabrizio, P., Laggerbauer, B., Lauber, J., Lane, W.S., and
Lu¨hrmann, R. (1997). An evolutionarily conserved U5 snRNP-
specific protein is a GTP-binding factor closely related to the
ribosomal translocase EF-2. EMBO J. 16, 4092–4106.
11. Ha¨cker, I., Sander, B., Golas, M.M., Wolf, E., Karago¨z, E.,
Kastner, B., Stark, H., Fabrizio, P., and Lu¨hrmann, R. (2008).
Localization of Prp8, Brr2, Snu114 and U4/U6 proteins in
the yeast tri-snRNP by electron microscopy. Nat. Struct. Mol.
Biol. 15, 1206–1212.
12. Achsel, T., Ahrens, K., Brahms, H., Teigelkamp, S., and Lu¨hr-
mann, R. (1998). The humanU5-220kD protein (hPrp8) forms
a stable RNA-free complex with several U5-specific proteins,
including an RNA unwindase, a homologue of ribosomal
elongation factor EF-2, and a novel WD-40 protein. Mol.
Cell. Biol. 18, 6756–6766.
13. Bartels, C., Klatt, C., Lu¨hrmann, R., and Fabrizio, P. (2002).
The ribosomal translocase homologue Snu114p is involved
in unwinding U4/U6 RNA during activation of the spliceo-
some. EMBO Rep. 3, 875–880.
14. Small, E.C., Leggett, S.R., Winans, A.A., and Staley, J.P. (2006).
The EF-G-like GTPase Snu114p regulates spliceosome
dynamics mediated by Brr2p, a DExD/H box ATPase. Mol.
Cell 23, 389–399.
15. Bartels, C., Urlaub, H., Luhrmann, R., and Fabrizio, P. (2003).
Mutagenesis suggests several roles of Snu114p in pre-mRNA
splicing. J. Biol. Chem. 278, 28324–28334.
16. Brenner, T.J., and Guthrie, C. (2005). Genetic analysis reveals
a role for the C terminus of the Saccharomyces cerevisiaeGTPase
Snu114 during spliceosome activation. Genetics 170, 1063–
1080.
17. Jørgensen, R., Ortiz, P.A., Carr-Schmid, A., Nissen, P., Kinzy,
T.G., and Andersen, G.R. (2003). Two crystal structures
demonstrate large conformational changes in the eukaryotic
ribosomal translocase. Nat. Struct. Biol. 10, 379–385.
18. Vithana, E.N., Abu-Safieh, L., Allen, M.J., Carey, A., Papaioan-
nou, M., Chakarova, C., Al-Maghtheh, M., Ebenezer, N.D.,
Willis, C., Moore, A.T., et al. (2001). A human homolog ofThe Americayeast pre-mRNA splicing gene, PRP31, underlies autosomal
dominant retinitis pigmentosa on chromosome 19q13.4
(RP11). Mol. Cell 8, 375–381.
19. McKie, A.B.,McHale, J.C., Keen, T.J., Tarttelin, E.E., Goliath, R.,
van Lith-Verhoeven, J.J., Greenberg, J., Ramesar, R.S., Hoyng,
C.B., Cremers, F.P., et al. (2001). Mutations in the pre-mRNA
splicing factor gene PRPC8 in autosomal dominant retinitis
pigmentosa (RP13). Hum. Mol. Genet. 10, 1555–1562.
20. Zhao, C., Bellur, D.L., Lu, S., Zhao, F., Grassi, M.A., Bowne, S.J.,
Sullivan, L.S., Daiger, S.P., Chen, L.J., Pang, C.P., et al. (2009).
Autosomal-dominant retinitis pigmentosa caused by a muta-
tion in SNRNP200, a gene required for unwinding of U4/U6
snRNAs. Am. J. Hum. Genet. 85, 617–627.
21. Tanackovic, G., Ransijn, A., Ayuso, C., Harper, S., Berson, E.L.,
and Rivolta, C. (2011). A missense mutation in PRPF6 causes
impairment of pre-mRNA splicing and autosomal-dominant
retinitis pigmentosa. Am. J. Hum. Genet. 88, 643–649.
22. He, H., Liyanarachchi, S., Akagi, K., Nagy, R., Li, J., Dietrich,
R.C., Li, W., Sebastian, N., Wen, B., Xin, B., et al. (2011). Muta-
tions in U4atac snRNA, a component of the minor spliceo-
some, in the developmental disorder MOPD I. Science 332,
238–240.
23. Schneider, C., Will, C.L., Makarova, O.V., Makarov, E.M., and
Lu¨hrmann, R. (2002). Human U4/U6.U5 and U4atac/
U6atac.U5 tri-snRNPs exhibit similar protein compositions.
Mol. Cell. Biol. 22, 3219–3229.
24. Dixon, J., Jones, N.C., Sandell, L.L., Jayasinghe, S.M., Crane, J.,
Rey, J.P., Dixon, M.J., and Trainor, P.A. (2006). Tcof1/Treacle is
required for neural crest cell formation and proliferation
deficiencies that cause craniofacial abnormalities. Proc. Natl.
Acad. Sci. USA 103, 13403–13408.
25. Gazda, H.T., Sheen, M.R., Vlachos, A., Choesmel, V., O’Dono-
hue, M.F., Schneider, H., Darras, N., Hasman, C., Sieff, C.A.,
Newburger, P.E., et al. (2008). Ribosomal protein L5 and L11
mutations are associated with cleft palate and abnormal
thumbs in Diamond-Blackfan anemia patients. Am. J. Hum.
Genet. 83, 769–780.n Journal of Human Genetics 90, 369–377, February 10, 2012 377
